Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q4 2017 Earnings

7NovConfirmed

Q1 2017

Q2 2017

Q3 2017

Q4 2017

-28.06

-25.65

-23.23

-20.82

Details

Expected EPS

-24.308600100000003

Actual EPS

-25.648444200000004

Surprise EPS

-1.34

Surprise Percent

+5.51%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -25.648444200000004 per share for Q4 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.